Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
1.532
-0.068 (-4.25%)
At close: Oct 27, 2025, 4:00 PM EDT
1.532
0.00 (0.00%)
After-hours: Oct 27, 2025, 4:10 PM EDT
MTNB Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
8.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.10M | -2.09M | -65.62% |
| Dec 31, 2022 | 3.19M | 3.16M | 9,560.61% |
| Dec 31, 2021 | 33.00K | -125.33K | -79.16% |
| Dec 31, 2020 | 158.33K | 68.52K | 76.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MTNB News
- 8 months ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 9 months ago - Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors - GlobeNewsWire
- 9 months ago - Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - GlobeNewsWire
- 10 months ago - Matinas BioPharma Receives NYSE Noncompliance Notice - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 1 year ago - Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 1 year ago - Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024 - GlobeNewsWire